University of Minnesota
240 Williamson Hall
231 Pillsbury Drive S.E.
Minneapolis
Minnesota
55455-0213
United States
Tel: 612-625-9051
Fax: 612-626-1693
Website: http://www.umn.edu/
Email: feedback@tc.umn.edu
About University of Minnesota
About the U of M
The University of Minnesota is one of the most comprehensive public universities in the United States and ranks among the most prestigious. It is both the state land-grant university, with a strong tradition of education and public service, and the state's primary research university, with faculty of national and international reputation.
The University of Minnesota's cutting-edge research and creation of new knowledge significantly contributes to world understanding and learning. As the state's primary research institution, the University receives 98 percent of all federally sponsored research grants awarded to higher education institutions in Minnesota.
The College of Biological Sciences at the University of Minnesota is one of few colleges nationwide devoted to biological sciences. CBS explores a world of opportunities, from molecules to ecosystems, to improve human health, develop renewable resources, enhance agriculture, and restore the environment.
Last Updated: 02-10-2006
231 articles with University of Minnesota
-
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
6/30/2022
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota.
-
As the world speculates the potential impact of the novel COVID-19 variant omicron XE and subvariant BA.2, research continues to shed light on the impact and future of the pandemic.
-
Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218
1/24/2022
HCW Biologics Inc. today announced that the Masonic Cancer Center, University of Minnesota was cleared by the U.S. Food and Drug Administration (FDA) to proceed to evaluate the Company’s lead drug candidate, HCW9218.
-
Here’s a look at 10 of the more compelling research stories of the year.
-
With the holidays around the corner and people expected to gather, public health officials have expressed concerns over a possible increase in COVID-19 cases, particularly with the highly infectious Omicron variant on the rise.
-
June really broke out in 2012 when he saved the life of Emily Whitehead, a child suffering from relapsed acute lymphoblastic leukemia (ALL), with CD19 CAR-T.
-
Hearing Restoration For The Deaf: Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL
9/15/2021
Blackrock Neurotech, a leading provider of brain computer interface technology for human patients, has announced plans to invest in a novel auditory nerve implant device that restores hearing for the deaf.
-
New research shows T cells can be engineered to migrate more effectively inside tumor microenvironments, raising hopes of reproducing the remarkable outcomes seen for certain hematological cancer patient subsets in broader populations and indications.
-
Inspired Spine Performs Highly Complex Multilevel Spinal Fusion at the University of Minnesota Hospital on a Patient with a BMI of 62.5
6/15/2021
An obese Ohio man suffering debilitating back pain began his search for relief by consulting with four different spine surgeons in his home state.
-
Biostasis Research Institute Launches to Enable Human "Organ Banks" Through the Cryogenic Storage of Donor Organs for Transplantation
4/21/2021
The Biostasis Research Institute launches by establishing and funding two new research centers at Massachusetts General Hospital and the University of Minnesota aimed at creating human organ banks through the cryogenic storage of organs donated for transplantation.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
A new report from University of Minnesota researchers shows that artificial heart valves implanted in lambs continued to grow and function for at least a year after surgery, a promising finding for pediatric patients in need of heart valve replacements.
-
NuWave® OxyPure® Air Purifier Found to Reduce Porcine Respiratory Coronavirus Concentration in the Air
10/28/2020
An Independent University of Minnesota Study Calculates the OxyPure® Reduces 99.999% Virus Concentration Within Six Hours
-
Study Pinpoints Five Most Likely Causes of Post-Traumatic Stress in Police Officers
8/11/2020
A combination of genetic and emotional differences may lead to post-traumatic stress in police officers, a new study finds.
-
NUWAY® and The Center for Practice Transformation at the University of Minnesota Research the Effects of Quality-Managed Recovery Housing on Addiction Treatment Outcomes
6/23/2020
NUWAY®, Minnesota's largest non-profit extended care addiction and mental healthcare treatment provider is partnering with The Center for Practice Transformation at the University of Minnesota to study the effects of recovery housing participation on addiction treatment and mental health outcomes.
-
UnitedHealth Group, Boston Scientific, Medtronic and the University of Minnesota Work to Deploy 3,000 Emergency Ventilator Alternative Devices
4/23/2020
Newly invented and U.S. Food and Drug Administration-authorized devices will help provide relief to impacted patients and enhance clinical capacity
-
Biomedical engineers at the University of Minnesota conducted a first-of-its-kind study on molecular interactions.
-
Minnesota Mix of Skilled Med Device Workforce and Clinical Partnerships Propels Abilitech™ Medical
10/15/2019
Abilitech wins 2019 MN Cup on its way to TEKNE competition, FDA registration prep and 75-patient clinical study
-
GT Biopharma Announces HIV Trike™ Data to be Published
9/26/2019
GT Biopharma, Inc. announced that Dr. Jeffrey Miller and colleagues from the University of Minnesota will present research results concerning an HIV TriKE™ which directs NK cell killing at HIV-infected CD4 T-cells.
-
Your Second Chance at a First Kiss®
8/20/2019
In 2018, Minnesota apple lovers fell in love with First Kiss®, the newest apple variety from the University of Minnesota’s (UMN) apple breeding program.